ARCHIVES

PDX Shows 27% Response In T-Cell Lymphoma In Study

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

NCI To File Record No. Of INDS In ’92, Expand Phase 1 Trials

March 6, 1992

NCI Suspend Tulane, LSU From Accrual Due To Missing Data

April 29, 1994

Capitol Hill: Mammography Quality standards Act Reintroduced

April 18, 1997

In Brief: Olden Chosen To Head NIEHS; Cancer Panel To Discuss Cancer and Poverty On July 9

June 28, 1991

Amgen Replaces “Bundling” Contract With Three Separate Contracts For Growth Factors.

September 5, 2008

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

March 25, 2011